Literature DB >> 11152481

Crystal structure of the mouse p53 core DNA-binding domain at 2.7 A resolution.

K Zhao1, X Chai, K Johnston, A Clements, R Marmorstein.   

Abstract

The p53 tumor suppressor is a sequence-specific DNA-binding protein that activates transcription in response to DNA damage to promote cell cycle arrest or apoptosis. The p53 protein functions in a tetrameric form in vivo and contains four domains including an N-terminal transcriptional activation domain, a C-terminal regulatory domain, a tetramerization domain, and a central core DNA-binding domain that is the site of the majority of tumor-derived mutations. Here we report the 2.7-A crystal structure of the mouse p53 core domain. Like the human p53 core domain in complex with DNA, the mouse p53 core domain adopts an immunoglobulin-like beta sandwich architecture with a series of loops and short helices at opposite ends of the beta sandwich. Comparison of the DNA-bound and DNA-free p53 core domains reveals that while the central beta sandwich architecture remains largely unchanged, a loop region important for DNA binding undergoes significant rearrangement. Although this loop region mediates major groove DNA contacts in the DNA-bound structure, it adopts a conformation that is incompatible with DNA binding in the DNA-free structure. Interestingly, crystals of the DNA-free core domain contain a noncrystallographic trimer with three nearly identical subunit-subunit (dimer) contacts. These dimer contacts align the p53 core domains in a way that is incompatible with simultaneous DNA binding by both protomers of the dimer. Surprisingly, similar dimer contacts are observed in crystals of the human p53 core domain with DNA in which only one of the three p53 protomers in the asymmetric unit cell is specifically bound to DNA. We propose that the p53 core domain dimer that is seen in the crystals described here represents a physiologically relevant inactive form of p53 that must undergo structural rearrangement for sequence-specific DNA binding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152481     DOI: 10.1074/jbc.M011644200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity.

Authors:  Michael A Resnick; Alberto Inga
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

2.  Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.

Authors:  Abdul S Ethayathulla; Pui-Wah Tse; Paola Monti; Sonha Nguyen; Alberto Inga; Gilberto Fronza; Hector Viadiu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

3.  Comparison of the protein-protein interfaces in the p53-DNA crystal structures: towards elucidation of the biological interface.

Authors:  Buyong Ma; Yongping Pan; K Gunasekaran; R Babu Venkataraghavan; Arnold J Levine; Ruth Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

4.  The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity.

Authors:  Andrei L Okorokov; Michael B Sherman; Celia Plisson; Vera Grinkevich; Kristmundur Sigmundsson; Galina Selivanova; Jo Milner; Elena V Orlova
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

Review 5.  Overview of protein structural and functional folds.

Authors:  Peter D Sun; Christine E Foster; Jeffrey C Boyington
Journal:  Curr Protoc Protein Sci       Date:  2004-05

6.  p53 binding to nucleosomal DNA depends on the rotational positioning of DNA response element.

Authors:  Geetaram Sahu; Difei Wang; Claudia B Chen; Victor B Zhurkin; Rodney E Harrington; Ettore Appella; Gordon L Hager; Akhilesh K Nagaich
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

7.  MORPHEEINS - A NEW PATHWAY FOR ALLOSTERIC DRUG DISCOVERY.

Authors:  Eileen K Jaffe
Journal:  Open Conf Proc J       Date:  2010

8.  Acetylation of the p53 DNA-binding domain regulates apoptosis induction.

Authors:  Stephen M Sykes; Hestia S Mellert; Marc A Holbert; Keqin Li; Ronen Marmorstein; William S Lane; Steven B McMahon
Journal:  Mol Cell       Date:  2006-12-28       Impact factor: 17.970

9.  Codon 104 variation of p53 gene provides adaptive apoptotic responses to extreme environments in mammals of the Tibet plateau.

Authors:  Yang Zhao; Ji-Long Ren; Ming-Yang Wang; Sheng-Ting Zhang; Yu Liu; Min Li; Yi-Bin Cao; Hu-Yue Zu; Xiao-Cheng Chen; Chung-I Wu; Eviatar Nevo; Xue-Qun Chen; Ji-Zeng Du
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

10.  Crystal structure of a p53 core tetramer bound to DNA.

Authors:  K A Malecka; W C Ho; R Marmorstein
Journal:  Oncogene       Date:  2008-11-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.